Completed Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex NCT03826628 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more Locations Phoenix Children's Hospital — Phoenix, Arizona, United States University of California San Diego — La Jolla, California, United States All Children's Research Institute — St. Petersburg, Florida, United States Spectrum Health — Grand Rapids, Michigan, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis NCT03140449 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more Locations Not specified View Trial Details
Completed Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream NCT01853423 Conditions Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more Locations LeBonheur Children's Hospital — Memphis, Tennessee, United States View Trial Details
